Guilly, Nahda M.
HRN: 23-82-65 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2023
CEFTRIAXONE 1G (VIAL)
10/02/2023
10/09/2023
IV
1.5
Q24
Pcap
Waiting Final Action